期刊文献+

卤代荧光素与西布曲明相互作用的共振散射光谱特征及其分析应用 被引量:5

Resonance Rayleigh Scattering Study of the Interaction of Sibutramine Hydrochloride with Halofluorescein and Its Analytical Applicaiton
下载PDF
导出
摘要 利用共振瑞利散射法,研究了乙基曙红、赤鲜红和荧光桃红3种卤代荧光素与盐酸西布曲明的相互作用,发现这3种卤代荧光素与盐酸西布曲明形成了离子缔合物,产生强烈的共振瑞利散射信号,其最大散射峰分别位于316、573和370nm;考察了适宜的反应条件及共存物质的影响,在一定范围内盐酸西布曲明的浓度与共振瑞利散射强度成正比,其线性范围分别是0.1~4.2mg·L^-1(乙基曙红-盐酸西布曲明体系)、0.09-6.0mg·L^-1(赤鲜红-盐酸西布曲明体系)、0.06~3.0mg·L^-1(荧光桃红-盐酸西布曲明体系),其检出限分别为32、28和21μg·L^-1;在赤鲜红-盐酸西布曲明体系中,573nm处的共振散射光谱偏振度P为0.95,表明体系的共振散射光谱主要由散射光构成。 The interactions of halofluorescein, such as ethyleosin(EE) , erythrosine (ET) and phloxine (PX), with sibutramine hydrochloride(SH) have been investigated by resonance Rayleigh scattering(RRS). It was found that SH could react with halofluoreseein to form ion-association complexes, resulting in a significant enhancement of RRS intensity. The RRS spectra of EE-SH, ET-SH and PX-SH complexes exhibited maximum peaks at 316, 573 and 370 nm, respectively. The optimum interaction conditions including solution pH, halofluorescein concentration, ionic strength, and formation and stabilization time have been studied. Under optimal conditions, the intensity of RRS was directly proportional to the concentration of SH in the range of 0. 1-4. 2 mg·L^-1 for EE - SH, 0. 09 -6.0 mg·L^-1 for ET-SH and 0. 06 - 3.0 mg·L^-1 for PX-SH complexes, respectively. The detection limits for SH in the system of EE-SH, ET-SH and PX-SH complexes were 32, 28 and 21μg·L^-1, respectively. The polarization(P) of RRS at 573 nm for ET-SH complex was 0. 95, indicating that the RRS spectrum of ET-SH was mainly composed of scattering light.
作者 周尚 杨季冬
出处 《分析测试学报》 CAS CSCD 北大核心 2008年第10期1058-1061,共4页 Journal of Instrumental Analysis
基金 重庆市教委资助项目(KJ051303)
关键词 西布曲明 卤代荧光素 共振瑞利散射 sibutramine halofluorescein resonance Rayleigh scattering(RRS)
  • 相关文献

参考文献5

  • 1左晓春,笪宏远.新一代减肥药──西布曲明[J].中国临床药理学杂志,2000,16(2):155-157. 被引量:27
  • 2秦宗会,谭蓉,蒲利军,江虹.刚果红褪色光度法测定盐酸西布曲明及作用机理研究[J].分析化学,2006,34(3):403-406. 被引量:16
  • 3RADHAKRISHNA T, LAKSHMI N C, VYAS K, et al. LC method for the determination of assay and purity of sibutramine hydrochloride and its enantiomers by chiral chromatography[ J]. J Pharm Biomed Anal, 2000, 22 (4) : 627 -639.
  • 4DING Li, HAO Xinyu, HUANG Xin. Simultaneous determination of sibutramine and its N-desmethyl metabolites in human plasma by liquid chromatography - electrospray ionization - mass spectrometry : Method and clinical applications [ J 1. Anal Chim Acta, 2003, 492(1/2) : 241 -248.
  • 5GARRATT C J, HIND I D, HADDOCK R E. Single/repeat dose kinetics of sibutramine metabolites in obeses subjects [J]. J Clin Pharm, 1995, 35:927 -928.

二级参考文献16

  • 1Radhakrishna T,Lakshmi Narayana C,Sreenivas Rao D,Vyas K,Reddy O.Journal of Pharmaceutical and Biomedical Analysis,2000,22(4):627~639.
  • 2Ding L,Hao X Y,Huang X,Zhang S Q.J.Anal.Chim.Acta,2003,492(1-2):241~248.
  • 3Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects (abstract)[].Journal of Clinical Pharmacology.1995
  • 4Drouin P,Hanotin C,Courciers,et al.A dose-ranging study efficacy andtolerability of sibutramine in weight loss[].Int J Ohes.1994
  • 5Study number SB 1049,Federal Drug Administration New Drug Approvalpackge [on-line]. http://w.w.w.fda gov cder /foi /ida /index 97 htm . 1998
  • 6.Meridia (sibutramine hydrolride monohydrate)Product information knollpharmaceutical conpany[]..1997
  • 7Bach DS,Rissanen AM,Mendel CM et.al.Absence of cardiac valvedysfunction in obese patients treated with sibutrsmine[].International Journal of Obesity.1998
  • 8Silverstone T.Appetitie suppressants:a review[].Drugs.1992
  • 9Bray,G.A.,Ryan,D.H.,Gordon,D.A double-blind randomized placebo-controlled trial of sibutramine[].Obesity Research.1996
  • 10Garratt CJ,Hind ID,Haddock RE.Single/repeat dose kinetics ofsibutramine metabolites in obeses subjects(abstract)[].Journal of Clinical Pharmacology.1995

共引文献40

同被引文献51

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部